METLIFE INC
METNYSEFinancials · Life Insurance · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $2.44B | $2.25B | $2.23B | $2.11B | $2.07B | $1.35B |
| Operating income | $6.14B | $6.00B | $5.72B | $5.98B | — | — |
| Net income | $3.38B | $4.43B | $1.58B | $5.28B | $6.86B | $5.41B |
| Total assets | $745.17B | $677.46B | $687.58B | $663.07B | $759.71B | $795.15B |
| Total liabilities | $716.25B | $649.75B | $657.33B | $632.95B | $691.96B | $720.33B |
| Equity | $28.40B | $27.45B | $30.02B | $29.88B | $67.48B | $74.56B |
| EPS (diluted) | $4.71 | $5.94 | $1.81 | $6.30 | $7.65 | $5.68 |
| Shares out. | 681.2M | 723.0M | 774.4M | 825.1M | 884.4M | 915.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 251.9%
- Net margin
- 138.7%
- Return on equity
- 11.9%
- Return on assets
- 0.5%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 96.1%
- Debt / equity
- 25.22×
- Book value / share
- $41.69
- Revenue growth (YoY)
- 8.5%
- Net income growth (YoY)
- −23.7%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- −1.8%clean
- Piotroski F-Score
- 4/8mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 warning● 4 good- High leverage (liabilities > 70% of assets)
- Operating margin is positive
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Board Of Directors Of Metlife IncActivist (13D)May 7, 2026
- Vanguard Capital Management LlcPassive (13G)Apr 30, 2026
- Vanguard Group IncPassive (13G)Mar 27, 2026
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| O'Neill Adrienne KarenOfficer — EVP & Chief Accounting Officer | Apr 30, 2026 | Grant | 12,485 | — |
| Harris Carla ADirector | Apr 1, 2026 | Grant | 721 | $71.17 |
| Seitz MichelleDirector | Apr 1, 2026 | Grant | 721 | $0.00 |
| Kennard William EDirector | Apr 1, 2026 | Grant | 721 | $71.17 |
| Hubbard Robert GlennDirector | Apr 1, 2026 | Grant | 1,248 | $71.17 |
| Morrison Denise MDirector | Apr 1, 2026 | Grant | 721 | $0.00 |
| Mumenthaler Christian StephaneDirector | Apr 1, 2026 | Grant | 721 | $71.17 |
| Hay Laura JDirector | Apr 1, 2026 | Grant | 721 | $71.17 |
| Mckenzie DianaDirector | Apr 1, 2026 | Grant | 721 | $71.17 |
| Glaser Daniel SDirector | Apr 1, 2026 | Grant | 721 | $71.17 |
| Gutierrez Carlos MDirector | Apr 1, 2026 | Grant | 721 | $0.00 |
| Weinberger Mark ADirector | Apr 1, 2026 | Grant | 721 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 12.1M | 3.8 | -2.1% |
| Apr 30, 2026 | 12.4M | 3.8 | -1.4% |
| Apr 15, 2026 | 12.5M | 3.7 | -11.2% |
| Mar 31, 2026 | 14.1M | 3.7 | +9.8% |
| Mar 13, 2026 | 12.9M | 3.0 | +15.6% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Other material eventMay 15, 2026
- Results of operations · Regulation FD disclosure · Other material eventMay 6, 2026
- Regulation FD disclosureApr 7, 2026
- Other material eventMar 5, 2026
- New financial obligation · Other material eventFeb 26, 2026
- Director / officer changeFeb 24, 2026
- Other material eventFeb 17, 2026
- Results of operations · Regulation FD disclosure · Other material eventFeb 4, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Corporate family
Spin-offs from METLIFE INC (1)
- Brighthouse Financial, Inc.BHFcompletedAug 4, 2017details
From the spin-off filings we track. Follow a company to walk its own history.
Event-driven situations (4)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.